Boston Scientific Shares Outstanding 2006-2018 | BSX
Boston Scientific shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Boston Scientific shares outstanding for the quarter ending September 30, 2018 were 1.404B, a 0.7% increase year-over-year.
- Boston Scientific 2017 shares outstanding were 1.393B, a 1.13% increase from 2016.
- Boston Scientific 2016 shares outstanding were 1.377B, a 2.68% increase from 2015.
- Boston Scientific 2015 shares outstanding were 1.341B, a 1.28% increase from 2014.
| Boston Scientific Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2017 | 1,393 |
| 2016 | 1,377 |
| 2015 | 1,341 |
| 2014 | 1,324 |
| 2013 | 1,341 |
| 2012 | 1,407 |
| 2011 | 1,519 |
| 2010 | 1,518 |
| 2009 | 1,508 |
| 2008 | 1,499 |
| 2007 | 1,487 |
| 2006 | 1,274 |
| 2005 | 838 |
| Boston Scientific Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| Q3 2018 | 1,404 |
| Q2 2018 | 1,399 |
| Q1 2018 | 1,397 |
| Q4 2017 | 1,393 |
| Q3 2017 | 1,394 |
| Q2 2017 | 1,391 |
| Q1 2017 | 1,390 |
| Q4 2016 | 1,377 |
| Q3 2016 | 1,380 |
| Q2 2016 | 1,357 |
| Q1 2016 | 1,370 |
| Q4 2015 | 1,341 |
| Q3 2015 | 1,344 |
| Q2 2015 | 1,362 |
| Q1 2015 | 1,334 |
| Q4 2014 | 1,324 |
| Q3 2014 | 1,348 |
| Q2 2014 | 1,345 |
| Q1 2014 | 1,349 |
| Q4 2013 | 1,341 |
| Q3 2013 | 1,340 |
| Q2 2013 | 1,359 |
| Q1 2013 | 1,352 |
| Q4 2012 | 1,407 |
| Q3 2012 | 1,393 |
| Q2 2012 | 1,423 |
| Q1 2012 | 1,454 |
| Q4 2011 | 1,519 |
| Q3 2011 | 1,524 |
| Q2 2011 | 1,536 |
| Q1 2011 | 1,536 |
| Q4 2010 | 1,518 |
| Q3 2010 | 1,529 |
| Q2 2010 | 1,525 |
| Q1 2010 | 1,515 |
| Q4 2009 | 1,508 |
| Q3 2009 | 1,509 |
| Q2 2009 | 1,515 |
| Q1 2009 | 1,505 |
| Q4 2008 | 1,499 |
| Q3 2008 | 1,501 |
| Q2 2008 | 1,505 |
| Q1 2008 | 1,500 |
| Q4 2007 | 1,487 |
| Q3 2007 | 1,490 |
| Q2 2007 | 1,500 |
| Q1 2007 | 1,498 |
| Q4 2006 | 1,274 |
| Q3 2006 | 1,487 |
| Q2 2006 | 1,327 |
| Q1 2006 | 830 |
| Q4 2005 | 838 |
| Q3 2005 | 820 |
| Q2 2005 | 840 |
| Q1 2005 | 850 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $49.097B | $9.048B |
| Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $126.569B | 18.92 |
| Abbott Laboratories (ABT) | United States | $122.855B | 24.89 |
| Stryker (SYK) | United States | $63.182B | 23.82 |
| Baxter (BAX) | United States | $34.600B | 22.34 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.421B | 14.54 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.589B | 0.00 |
| ResMed (RMD) | United States | $15.674B | 29.89 |
| Perrigo (PRGO) | Ireland | $8.142B | 12.36 |
| Bio-Rad Laboratories (BIO) | United States | $7.677B | 49.09 |
| Canopy Growth (CGC) | Canada | $7.290B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $6.241B | 19.53 |
| Aurora Cannabis (ACB) | Canada | $5.730B | 30.26 |
| Haemonetics (HAE) | United States | $5.332B | 46.90 |
| Insulet (PODD) | United States | $4.770B | 0.00 |
| ICU Medical (ICUI) | United States | $4.752B | 26.48 |
| Hutchison China MediTech (HCM) | China | $4.204B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.765B | 0.00 |
| Neogen (NEOG) | United States | $3.198B | 48.43 |
| Agios Pharmaceuticals (AGIO) | United States | $3.093B | 0.00 |
| NuVasive (NUVA) | United States | $2.886B | 26.85 |
| National Vision Holdings (EYE) | United States | $2.497B | 48.30 |
| NxStage Medical (NXTM) | United States | $1.925B | 0.00 |
| Quidel (QDEL) | United States | $1.917B | 24.99 |
| Phibro Animal Health (PAHC) | United States | $1.327B | 18.78 |
| Aphria (APHA) | $1.306B | 0.00 | |
| AtriCure (ATRC) | United States | $1.204B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $0.991B | 1428.00 |
| VAREX IMAGING (VREX) | United States | $0.918B | 18.37 |
| PetIQ (PETQ) | United States | $0.886B | 22.96 |
| Meridian Bioscience (VIVO) | United States | $0.778B | 24.80 |
| Surmodics (SRDX) | United States | $0.766B | 116.65 |
| OraSure Technologies (OSUR) | United States | $0.752B | 42.35 |
| Cerus (CERS) | United States | $0.726B | 0.00 |
| MacroGenics (MGNX) | United States | $0.693B | 0.00 |
| Omeros (OMER) | United States | $0.687B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.655B | 21.00 |
| Lantheus Holdings (LNTH) | United States | $0.652B | 20.17 |
| NanoString Technologies (NSTG) | United States | $0.527B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.502B | 24.65 |
| Owens & Minor (OMI) | United States | $0.433B | 4.90 |
| Quanterix (QTRX) | United States | $0.433B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.414B | 0.00 |
| Insys Therapeutics (INSY) | United States | $0.385B | 0.00 |
| Evolus (EOLS) | United States | $0.375B | 0.00 |
| VAPOTHERM INC (VAPO) | United States | $0.350B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.339B | 21.90 |
| Cytosorbents (CTSO) | United States | $0.295B | 0.00 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.243B | 0.00 |
| Surface Oncology (SURF) | United States | $0.226B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.207B | 279.25 |
| Rockwell Medical (RMTI) | United States | $0.172B | 0.00 |
| Chimerix (CMRX) | United States | $0.167B | 0.00 |
| Fonar (FONR) | United States | $0.135B | 6.77 |
| Imprimis Pharmaceuticals (IMMY) | United States | $0.115B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.108B | 0.00 |
| United-Guardian (UG) | United States | $0.079B | 16.53 |
| Female Health (VERU) | United States | $0.076B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.070B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.066B | 18.27 |
| CAS Medical Systems (CASM) | United States | $0.055B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.052B | 0.00 |
| Neurotrope (NTRP) | United States | $0.043B | 0.00 |
| ImmuCell (ICCC) | United States | $0.041B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.021B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.019B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.017B | 0.00 |
| Senestech (SNES) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.006B | 0.00 |
